Table: begin end state 1 19 cytoplasmic 20 43 transmembrane 44 57 non-cytoplasmic 58 77 transmembrane 78 87 cytoplasmic 88 107 transmembrane 108 112 non-cytoplasmic 113 134 transmembrane 135 145 cytoplasmic 146 168 transmembrane 169 173 non-cytoplasmic 174 195 transmembrane 196 251 cytoplasmic 252 272 transmembrane 273 287 non-cytoplasmic 288 310 transmembrane 311 317 cytoplasmic 318 336 transmembrane 337 341 non-cytoplasmic 342 363 transmembrane 364 382 cytoplasmic 383 404 transmembrane 405 409 non-cytoplasmic 410 429 transmembrane 430 455 cytoplasmic
Input: >HSERO_RS06575 MKTLDVSQIIDGARFTKFHWMVMCLCALLLVFDGYDLFIYGAVLPVLMKEWSLSPVQAGA LGSYALFGMMFGAFIFGPLADRIGRKKGVAISFVLFSVSTFLSGFATSPTEFGVYRFLAG LGCGGLMPNAVALMNEYAPKRLRSTLVAIMFSGYSLGGVLCAGLGIWMLPNFGWQSMFFA AAVPLVLLPVILWKLPESVGFLLRQGRLEQARAMLTQVDPQARIATDTQLVQADVKGAGA PMLHLFKQDRAVGTLMIWVSFFCCLLMVYALGSWLPKLMASAGYSLGSSLSFLLALNFGG VVGAIGGGWLGDRFTLPKVVVSFFTVGTVAIALLGFNSPTPVLYLLIIVAGATTIGTQIL LYANTAQFYPLAIRSTGLGWASGVGRSGAIVGPLLGGALMAAALPLKMNFLVFAIPGLVA ALAMGLFMLRYRHGSQASHAAPAAKAPPAAASRSV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server